Fellowship · Tampa, FL
Sponsored by University of South Florida Morsani College of Medicine
Precision medicine advances in idiopathic pulmonary fibrosis.
EBioMedicine · 2023 · 106 citations · Jose Herazo-Maya
Single-Cell Profiling Reveals Immune Aberrations in Progressive Idiopathic Pulmonary Fibrosis.
American journal of respiratory and critical care medicine · 2024 · 76 citations · Jose Herazo-Maya
Monocytes and macrophages: emerging mechanisms and novel therapeutic targets in pulmonary fibrosis.
American journal of physiology. Cell physiology · 2023 · 79 citations · Jose Herazo-Maya
A lung targeted miR-29 mimic as a therapy for pulmonary fibrosis.
EBioMedicine · 2022 · 102 citations · Jose Herazo-Maya
The Dawn of Precision Medicine in Fibrotic Interstitial Lung Disease.
Chest · 2025 · 23 citations · Jose Herazo-Maya
The transcriptome of CD14+CD163-HLA-DRlow monocytes predicts mortality in idiopathic pulmonary fibrosis.
The European respiratory journal · 2026 · 6 citations · Jose Herazo-Maya
Evolution of pulmonary hypertension in interstitial lung disease: a journey through past, present, and future.
Frontiers in medicine · 2023 · 19 citations · Jose Herazo-Maya
eNAMPT Is a Novel DAMP and Therapeutic Target in Human and Murine Pulmonary Fibrosis.
American journal of respiratory cell and molecular biology · 2025 · 11 citations · Jose Herazo-Maya